The new Biden administration and a post-pandemic world on the horizon present a landscape of evolving policy, legislative reform, and regulatory and criminal enforcement priorities. Our Task Force is drawing on first-hand prior senior government and Capitol Hill experience to help our clients across industries navigate this new world.
King & Spalding’s Government Matters Practice is uniquely positioned to help clients as the new administration’s rapidly unfolding priorities impact their business operations. We offer strategic guidance across all things government-facing, including handling complex agency interactions, developing and implementing strategies involving Congress and the Executive Branch, navigating challenging investigations and litigation, and protecting and advancing client interests.
We have decades of experience with regulatory and criminal enforcement investigations by the DOJ, SEC, CFTC, FDA, HHS, EPA, FTC, DOD, USTR, Commerce, Customs, OFAC and CFIUS. We have a deep bench of lawyers who have served in administrations of both parties, and we leverage our bipartisan relationships to optimize results in Washington, and at the state and local levels. With a global cross-disciplinary platform, we bring the right experience and relationships to bear and provide quick, integrated and seamless solutions to complex government-related challenges.
This page is intended as a resource to allow our clients to understand and monitor key issues and developments regarding the new administration and the evolving pandemic environment.
The Biden Administration’s economic policy actions and the emerging legislative proposals in Congress now create new business opportunities – with accompanying new risks – in the Buy American space.Read More
A high-level overview of expected regulatory changes, support for ESG initiatives and renewed focus on criminal investigations and enforcement.Read More
A high-level overview of five areas where we expect the DOJ and other regulators to focus, including market manipulation, the activities of Wall Street banks, AML, congressional oversight, and consumer protection.Read More
A high-level overview of important changes in U.S. government policy, regulation and enforcement priorities for life sciences companies.Read More
A high-level overview of key trends on the horizon affecting U.S. manufacturers, including domestic supply chains, climate change and U.S.-China relations.Read More
A high-level overview of new legislation, anticipated rules and regulations, and trends that we think will impact activity in the healthcare industry.Read More
A high-level overview of key areas where we expect the new administration to focus, including FDA regulatory priorities, the U.S. domestic supply chain, climate change policies, U.S.-EU (trade) relationships and imports into the U.S.Read More
September 27, 2021
20 State Attorneys General Push Congress to Address Environmental Justice